Literature DB >> 2007892

Early treatment time course of depressive symptoms in opiate addicts.

E C Strain1, M L Stitzer, G E Bigelow.   

Abstract

Self-reported depressive symptoms of opiate addicts were assessed at admission to a methadone treatment program and weekly during the first 4 treatment weeks using the Beck Depression Inventory. A significant decline in scores was found to occur with the first follow-up evaluation done 7 days after admission, with scores remaining stable over subsequent weeks. The study suggests that a more accurate assessment of psychiatric symptoms may be obtained by waiting 1 to 2 weeks after treatment entry as compared with admission assessments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007892     DOI: 10.1097/00005053-199104000-00007

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  22 in total

1.  Treating depression and substance use: a randomized controlled trial.

Authors:  Sarah B Hunter; Katherine E Watkins; Kimberly A Hepner; Susan M Paddock; Brett A Ewing; Karen C Osilla; Suzanne Perry
Journal:  J Subst Abuse Treat       Date:  2012-02-01

2.  The effect of a case management intervention on drug treatment entry among treatment-seeking injection drug users with and without comorbid antisocial personality disorder.

Authors:  Jennifer R Havens; Llewellyn J Cornelius; Erin P Ricketts; Carl A Latkin; David Bishai; Jacqueline J Lloyd; Steven Huettner; Steffanie A Strathdee
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

3.  Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons.

Authors:  Michael D Stein; Debra S Herman; Malyna Kettavong; Patricia A Cioe; Peter D Friedmann; Tahir Tellioglu; Bradley J Anderson
Journal:  J Subst Abuse Treat       Date:  2010-07-03

Review 4.  On beyond urine: clinically useful assessment instruments in the treatment of drug dependence.

Authors:  K M Carroll; B J Rounsaville
Journal:  Behav Res Ther       Date:  2002-11

5.  The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients.

Authors:  Michelle Tuten; Sarah H Heil; Kevin E O'Grady; Heather Fitzsimons; Margaret S Chisolm; Hendrée E Jones
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

6.  The association between naltrexone treatment and symptoms of depression in opioid-dependent patients.

Authors:  David J Mysels; Wendy Y Cheng; Edward V Nunes; Maria A Sullivan
Journal:  Am J Drug Alcohol Abuse       Date:  2010-12-30       Impact factor: 3.829

7.  Early outcomes following low dose naltrexone enhancement of opioid detoxification.

Authors:  Paolo Mannelli; Ashwin A Patkar; Kathleen Peindl; Edward Gottheil; Li-Tzy Wu; David A Gorelick
Journal:  Am J Addict       Date:  2009 Mar-Apr

8.  A comparison of two depressive symptomatology measures in residential substance abuse treatment clients.

Authors:  Kimberly A Hepner; Sarah B Hunter; Maria O Edelen; Annie J Zhou; Katherine Watkins
Journal:  J Subst Abuse Treat       Date:  2009-04-08

9.  Meta-analysis of depression and substance use and impairment among cocaine users.

Authors:  Kenneth R Conner; Martin Pinquart; Amanda P Holbrook
Journal:  Drug Alcohol Depend       Date:  2008-06-27       Impact factor: 4.492

10.  Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients.

Authors:  Margaret S Chisolm; Michelle Tuten; Emily C Brigham; Eric C Strain; Hendrée E Jones
Journal:  Am J Addict       Date:  2009 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.